Search results
GSK blood cancer drug nearly halves risk of death in late-stage trial
Reuters via AOL· 4 days agoGSK's multiple myeloma drug Blenrep nearly halved the risk of disease progression or death compared...
Become part of a movement to accelerate a cure for multiple myeloma!
Digital Journal· 19 hours agoPRESS RELEASE Published June 5, 2024 24-7 Press Release Multiple Myeloma Research Foundation® Walk/Run DETROIT, MI, June 05, 2024 /24-7PressRelease/ -- ...
Sarclisa Combination Improves Progression-Free Survival in Patients with Newly Diagnosed...
Pharmaceutical Executive Magazine· 1 day agoEffective frontline therapy has the potential to modify the course of the disease, which is a key...
CARVYKTI® (ciltacabtagene autoleucel) significantly improved progression-free survival and deepened...
Valley City Times Record· 2 days agoJohnson & Johnson announced today results from a subgroup analysis of the Phase 3 CARTITUDE-4 study. Data from the CARTITUDE-4 study supported the recent U.S. FDA approval of CARVYKTI®, the ...
EXCLUSIVE: Telo Genomics' Smoldering Multiple Myeloma Prognostic Test Predicts Risk Of Disease...
Benzinga· 6 days agoAmerican Journal of Hematology accepts Telo Genomics' study on TeloViewSMM, a prognostic test for smoldering multiple myeloma. The test showed 85% positive ...
Quadruplet Regimens Have Become Standard for Multiple Myeloma
MedPage Today· 6 days agoWhile triplet regimens were once standard for newly diagnosed multiple myeloma, more recent studies...
Paul Mescal's mum shares cancer battle update
Digital Spy via AOL· 11 hours agoThe actor's mother, who has shared regular social media posts about her cancer journey, was first diagnosed with multiple myeloma in 2022, a cancer that...
GSK's Blenrep Combo Therapy Cuts Risk Of Disease Progression Or Death By Around 50% In Pretreated ...
Benzinga via Yahoo Finance· 2 days agoThe data were presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting. On...
Adding Isatuximab to Standard Backbone Improves Outcomes in Multiple Myeloma
MedPage Today· 2 days agoTwo trials show positive outcomes
DARZALEX® (daratumumab)-based regimens significantly improve clinical outcomes in both...
Valley City Times Record· 2 days agoThe rates of deep and sustained MRD negativity were associated with improved progression-free...
